ESC Premium Access

State of the Art - Diagnosis of heart failure with preserved ejection fraction: What's new?

Congress Session

About the speaker

Professor Burkert Pieske

Charite University Hospital, Berlin (Germany)
50 presentations
1 follower

4 more presentations in this session

Metabolomic profile of patients with new onset heart failure; more microvascular dysfunction in patients with preserved ejection fraction compared to reduced ejection fraction - the PREFERS Study

Speaker: Assistant Professor C. Hage (Stockholm, SE)

Thumbnail

Different impact of muscle, fat, and bone mass in heart failure with reduced and preserved ejection fraction

Speaker: Doctor M. Konishi (Yokohama, JP)

Thumbnail

Serum Trimethylamine N-Oxide levels and 16S rRNA gut microbiota profiling in patients with heart failure and preserved ejection fraction and healthy individuals

Speaker: Professor O. Drapkina (Moscow, RU)

Thumbnail

Heart failure with preserved ejection fraction: how to further improve patient outcomes?

Speaker: Doctor M. Senni (Bergamo, IT)

Thumbnail

Access the full session

Heart failure with preserved ejection fraction

Speakers: Professor B. Pieske, Assistant Professor C. Hage, Doctor M. Konishi, Professor O. Drapkina, Doctor M. Senni
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

HFA Premium Access

The fantastic four of heart failure treatment: do we know how to use them? - discussion.

21 May 2022

Open Access

CCM in the future: looking ahead to drive heart failure device treatment.

21 May 2022

Open Access

CCM: a historical perspective.

21 May 2022

This platform is supported by

logo Novo Nordisk